The TCA Cycle: Acceptor Pools, Electron Yield, and Disease
Connect the eight TCA reactions to pyruvate entry, ATP accounting, metabolic replenishment, inherited disease, toxic inhibition, and cancer metabolism.
The TCA cycle does not manufacture a new four-carbon acceptor every time acetyl-CoA enters. It regenerates the acceptor it borrowed. That distinction explains why a person can oxidize fat yet still need glucose precursors, and why draining intermediates can compromise energy production despite an abundant fuel supply.
Before the cycle: decide whether pyruvate becomes fuel or reserve
Pyruvate reaches the mitochondrial matrix through transport machinery, then faces competing routes. Pyruvate dehydrogenase, or PDH, produces acetyl-CoA, carbon dioxide and NADH. This oxidative decarboxylation is effectively irreversible in human metabolism. Pyruvate carboxylase instead spends ATP to add bicarbonate, producing oxaloacetate. The first route extracts energy from carbon; the second replenishes a cycle intermediate or starts gluconeogenesis. A high acetyl-CoA supply activates pyruvate carboxylase, helping match the available acceptor to incoming fuel. [2][9]
PDH is a multienzyme complex. E1 uses thiamine pyrophosphate to decarboxylate pyruvate. E2 uses a covalently attached lipoyl group to transfer the resulting acetyl group to coenzyme A. E3 uses FAD and NAD to reoxidize the reduced lipoyl system. The five usual cofactor names therefore correspond to four vitamin sources: thiamine, riboflavin, niacin and pantothenate, plus lipoate. Lipoate is not a fifth B vitamin. CoA carries the acetyl group, while NADH carries reducing equivalents. The same five-cofactor architecture is used by alpha-ketoglutarate dehydrogenase, but not by every enzyme with “dehydrogenase” in its name.
PDH kinase phosphorylates and inhibits the complex; PDH phosphatase reverses that inhibition. Abundant NADH and acetyl-CoA signal that oxidative fuel delivery is already high. Pyruvate availability and tissue-specific demand signals favor oxidation when needed. In contracting muscle, calcium can couple demand to activation of oxidative metabolism. A phosphorylation diagram must identify its enzyme: phosphorylation inhibits PDH and liver pyruvate kinase, so it cannot mean “activate all energy-producing pathways.”
Primary PDH complex deficiency commonly affects neurological development and produces elevated lactate and pyruvate. The lactate-to-pyruvate ratio is often relatively normal compared with respiratory redox defects, but collection conditions and overlapping disease limit any single ratio as a diagnosis. PDHA1 disease is X-linked; other components can have autosomal recessive causes. Some patients respond to thiamine and some benefit from specialist ketogenic therapy. Neither fact justifies withholding rescue glucose during hypoglycemia or prescribing the same diet to every child with lactic acidosis. [2][14]
Try it here · Checkpoint 1 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 6
Show answer and explanations for case 6
A. Phosphatase activity favors inhibitory phosphorylation. (Why this does not fit)
A phosphatase removes phosphate; the kinase adds the inhibitory phosphate.
B. Dephosphorylation inhibits E1 and redirects all pyruvate toward lactate. (Why this does not fit)
For PDH, dephosphorylation favors activity rather than this inhibition.
C. Dephosphorylation favors activation. (Best answer)
Removing inhibitory phosphate helps match pyruvate oxidation to demand.
D. PDH directly produces oxaloacetate after dephosphorylation. (Why this does not fit)
The regulated reaction still makes acetyl-CoA; pyruvate carboxylase makes oxaloacetate.
Takeaway: Identify whether the phosphate activates or inhibits the particular enzyme.
One turn: preserve four carbons, release energy in stages
The cycle runs principally in the mitochondrial matrix. Succinate dehydrogenase is the spatial exception: it is embedded in the inner mitochondrial membrane as respiratory complex II, with its catalytic machinery facing the matrix. The eight reactions below are ordered so the energy payments and carbon losses can be inspected without opening a separate view. [1]
One acetyl-CoA enters; oxaloacetate returns
Citrate synthase: oxaloacetate, four carbons, combines with acetyl-CoA, two carbons, to form citrate, six carbons. Thioester hydrolysis helps drive condensation.
Aconitase: citrate is rearranged through cis-aconitate to isocitrate. Water is removed and re-added; there is no net NADH payment or carbon loss. Its iron-sulfur center matters.
Isocitrate dehydrogenase: the oxidative cycle enzyme IDH3 forms alpha-ketoglutarate, carbon dioxide and NADH. Six carbons become five.
Alpha-ketoglutarate dehydrogenase: five carbons become the four-carbon succinyl-CoA, with another carbon dioxide and NADH.
Succinyl-CoA synthetase: thioester energy supports substrate-level phosphorylation while succinate forms. A GDP-specific isoenzyme yields GTP; an ADP-specific isoenzyme yields ATP.
Succinate dehydrogenase: succinate becomes fumarate. Enzyme-bound FAD and iron-sulfur centers pass electrons to ubiquinone.
Fumarase: hydration forms L-malate, without an ATP or NADH payment.
Malate dehydrogenase: malate oxidation restores oxaloacetate and yields the third NADH. Citrate synthase consumption of oxaloacetate helps sustain this otherwise unfavorable standard-state reaction.
The sequence returns to the first line. The final four-carbon molecule is an acceptor regenerated by the cycle, not four new carbons created from acetyl-CoA.
Per turn, the usual ledger is three NADH, one FAD-linked electron pair, one GTP or ATP, and two carbon dioxide molecules. The two carbons newly arriving in acetyl-CoA are not the carbon dioxide released during that first turn. They mix into the intermediate pool and can be lost on later turns. This matters in isotope tracing: net stoichiometry does not tell you which labeled atom leaves first.
Isocitrate dehydrogenase and alpha-ketoglutarate dehydrogenase respond to energy and redox conditions. ADP and calcium can stimulate oxidative flux in appropriate tissue settings; high NADH opposes further oxidation. There is no value in forcing another oxidation if the electron acceptors cannot be regenerated. Calling one enzyme the universal “rate-limiting step” hides the fact that control is distributed among substrate supply, these enzymes and respiration.
ATP yield depends on where electrons enter
The cycle directly makes only one nucleotide triphosphate per acetyl unit. Most of its useful energy is conserved as reduced cofactors whose electrons support respiratory proton pumping. Using conventional teaching estimates of about 2.5 ATP per mitochondrial NADH and 1.5 ATP per FAD-linked pair entering at ubiquinone gives 7.5 + 1.5 + 1 = 10 ATP equivalents per acetyl-CoA. These are accounting estimates, not a promise that every living cell realizes the same yield.
Matrix NADH: electrons enter complex I, then ubiquinone, complex III and complex IV. The extra proton-pumping contribution at complex I helps explain the higher estimate.
Succinate oxidation: complex II transfers electrons to ubiquinone. Complex II does not pump protons, so this entry skips the contribution at complex I.
Cytosolic NADH: the inner membrane does not freely admit NADH. Shuttle reactions transfer its reducing equivalents; they do not simply carry the NADH molecule through a pore.
In the malate-aspartate shuttle, cytosolic oxaloacetate is reduced to malate, which can enter the matrix and be oxidized to regenerate matrix NADH. Aspartate/glutamate transamination and transport complete the exchange. Malate dehydrogenase performs the redox reaction; aspartate aminotransferase performs transamination. In the glycerol phosphate shuttle, cytosolic NADH reduces dihydroxyacetone phosphate. Mitochondrial GPD2 oxidizes glycerol 3-phosphate using bound FAD and passes electrons to the quinone pool. This does not require entry through succinate dehydrogenase. [3][13]
Complete oxidation of one glucose is conventionally estimated at about 30 to 32 ATP: two direct glycolytic ATP, two PDH NADH, two TCA turns, and the two cytosolic glycolytic NADH handled by shuttles. The two TCA turns alone contribute about 20 ATP equivalents. The shuttle-dependent difference reflects electron-entry energetics, not two ATP physically spent to push NADH across the membrane. Tissue expression, metabolic state and coupling influence actual use and yield.
Oxygen is not a substrate of the eight TCA reactions, but sustained oxidative cycling depends on respiration regenerating NAD and oxidized electron carriers. Cyanide inhibition of complex IV therefore backs up redox metabolism and can raise lactate. A mature erythrocyte lacks this entire mitochondrial apparatus; it cannot choose a better shuttle to gain oxidative ATP. [3]
The curated human GPD2 reaction explicitly pairs glycerol 3-phosphate oxidation with quinone reduction. This is the biochemical basis for treating its electron entry separately from succinate oxidation through complex II. [13]
Try it here · Checkpoint 2 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 16
Show answer and explanations for case 16
A. How cytosolic glycolytic NADH reducing equivalents reach respiration (Best answer)
Entry through a quinone-linked shuttle gives a lower estimate than matrix NADH entry through complex I.
B. The lower estimate assumes only one TCA turn per glucose. (Why this does not fit)
Two pyruvates still yield two acetyl units and two turns.
C. The higher estimate omits both glycolytic ATP investment reactions. (Why this does not fit)
Both conventional complete-glucose calculations include the investment and payoff.
D. Two ATP are directly spent importing intact NADH in the lower-yield case. (Why this does not fit)
Shuttles use reaction and transport cycles rather than an ATP-powered NADH pump.
Takeaway: The 30-to-32 estimate reflects electron-entry accounting, not a transport fee.
The cycle is also a source of building material. Citrate export supports cytosolic fatty acid and cholesterol synthesis. Alpha-ketoglutarate can exchange nitrogen with glutamate. Oxaloacetate supplies aspartate, and succinyl-CoA contributes to heme synthesis. Using an intermediate outside the cycle is a withdrawal from the pool. Continued oxidation then depends on replacement, called anaplerosis. This is why a large acetyl-CoA supply alone cannot compensate for losing every four-carbon acceptor.
Pyruvate carboxylase is a major replenishing reaction. It uses biotin, ATP and bicarbonate; it does not produce NADH as its direct purpose. Its deficiency can produce lactic acidosis through impaired anaplerosis and gluconeogenesis, with severity varying among clinical forms. Distinguish it from PDH deficiency: PDH loses pyruvate-derived acetyl entry, while pyruvate carboxylase loses a way to replenish oxaloacetate. That distinction affects dietary reasoning and prevents using a PDH ketogenic strategy indiscriminately. [9][11]
Propionyl-CoA provides another entry. It arises from odd-carbon fatty acid metabolism and selected amino acids. Biotin-dependent propionyl-CoA carboxylase produces methylmalonyl-CoA; after epimerization, cobalamin-dependent methylmalonyl-CoA mutase produces succinyl-CoA. [16] Valine and part of isoleucine catabolism can reach this route. [15] Leucine is exclusively ketogenic and cannot be treated as a succinyl-CoA source. The human cycle also does not synthesize essential branched amino acids from scratch merely because reversible transaminases exist. [19]
The urea cycle returns fumarate after aspartate donates nitrogen. Fumarate can become malate and oxaloacetate, reconnecting nitrogen disposal with carbon metabolism. Aminotransferase reactions redistribute nitrogen while retaining useful carbon skeletons. Elevated serum AST or ALT after injury reflects release of intracellular enzymes; it is not a quantitative measurement of how much alpha-ketoglutarate the patient's liver is consuming. [23]
When the same pathway causes acidosis, poisoning or tumors
Thiamine depletion can impair both PDH and alpha-ketoglutarate dehydrogenase. Neurological dysfunction and lactic acidosis can coexist because oxidative carbon processing and ATP production are compromised. Niacin depletion limits NAD precursors; riboflavin and pantothenate provide FAD and CoA components. Riboflavin deficiency can also produce angular stomatitis, cracked lips and red, itchy eyes. These findings are nonspecific and often coexist with other nutritional deficiencies. [25] This is cofactor physiology, not a recommendation to treat unexplained acidosis with vitamins alone. Stabilization and investigation of infection, perfusion, exposures and inherited disorders must follow the clinical setting. [2][10]
Arsenic has multiple toxic effects; trivalent arsenic interferes with lipoate-associated metabolism, including PDH and alpha-ketoglutarate dehydrogenase. Arsenate, the pentavalent form, can disrupt phosphate-dependent energy conservation. Fluoroacetate is metabolized to fluorocitrate, which inhibits aconitase. Malonate is an experimental competitive inhibitor of succinate dehydrogenase. Malonate has three carbons and resembles four-carbon succinate sufficiently to compete; they do not have the same carbon count.
These comparisons explain mechanisms, but a bedside toxicology diagnosis needs an exposure history and appropriate testing. Suspected acute arsenic poisoning needs urgent supportive stabilization and medical toxicology input. Chelation, including consideration of dimercaprol, depends on the exposure and clinical state; early treatment may matter, but the drug has substantial risks. Chronic exposure instead prioritizes finding and ending the source. [20][8]
Inherited enzyme defects have another consequence: abnormal metabolite signals. SDH loss permits succinate accumulation, which can inhibit alpha-ketoglutarate-dependent prolyl hydroxylation and stabilize hypoxia signaling despite available oxygen. This pseudohypoxic biology helps explain SDHx-related tumor predisposition. Succinate, not fumarate, is the substrate immediately upstream of the SDH block. FH loss impairs fumarate hydration, so fumarate accumulates. Biallelic FH deficiency can cause severe but variable neurological disease; heterozygous pathogenic variants can confer a distinct tumor predisposition. The inheritance context matters as much as the enzyme name. [5][6][7]
Cancer-associated IDH1 and IDH2 must be distinguished from the NAD-dependent IDH3 of the oxidative cycle. Normal IDH1/2 use NADP-linked chemistry in different compartments. Certain mutant enzymes acquire the ability to reduce alpha-ketoglutarate to D-2-hydroxyglutarate using NADPH. [17] They do not simply convert isocitrate directly to that product by losing all enzyme activity. The acquired metabolite production is central to the disease mechanism.
D-2-hydroxyglutarate can inhibit alpha-ketoglutarate-dependent histone demethylases and TET-family DNA hydroxylases, altering histone and DNA methylation. This provides a mechanistic connection to impaired differentiation and tumor biology; it does not imply identical epigenetic effects in every IDH-mutant tumor. The original therapeutic examples also require a defined disease: a 2018 study reported responses to the mutant-IDH1 inhibitor ivosidenib in some adults with relapsed or refractory IDH1-mutant AML.
The FDA approved the mutant-IDH2 inhibitor enasidenib in 2017 for adults with relapsed or refractory AML and the relevant mutation. These examples connect the acquired enzyme activity to treatment; they are not a complete current prescribing guide for every IDH-mutant cancer. [21][22][18][4]
Finally, mitochondrial location does not prove mitochondrial DNA inheritance. Core TCA enzymes are nuclear encoded. Mitochondrial respiratory disease can involve either genome; heteroplasmy and tissue distribution can make maternally transmitted mitochondrial DNA disease vary among relatives. Do not tell a family that every child must have identical severity or that a nuclear PDH variant follows maternal mitochondrial inheritance. [24][2][6]
Structural and biochemical experiments on the fluorocitrate-aconitase complex support the enzyme-level inhibition described above. This mechanistic evidence does not replace clinical exposure assessment. [12]
Try it here · Checkpoint 3 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 24
Show answer and explanations for case 24
A. Succinate (Best answer)
SDH normally oxidizes succinate to fumarate, so loss favors succinate accumulation.
B. Fumarate (Why this does not fit)
Fumarate is the immediate product, not the upstream substrate of SDH.
C. Citrate only (Why this does not fit)
Citrate is several reactions away and is not the defining SDH substrate.
D. D-2-hydroxyglutarate from acquired mutant IDH1 activity (Why this does not fit)
That is a different oncogenic enzyme mechanism not established by SDHB.
Takeaway: SDH loss and FH loss accumulate different metabolites.
